2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies|
- Influenza vaccination [ Time Frame: One year/influenza season ] [ Designated as safety issue: No ]
- Influenza non-vaccine infection control strategies [ Time Frame: One year/influenza season ] [ Designated as safety issue: No ]
- Veterans and health care providers attitudes and beliefs about H1N1 [ Time Frame: One year/influenza season ] [ Designated as safety issue: No ]
|Study Start Date:||July 2010|
|Estimated Study Completion Date:||August 2011|
|Estimated Primary Completion Date:||April 2011 (Final data collection date for primary outcome measure)|
Veterans with spinal cord injuries and disorders
Comparison group: general Veteran population (without spinal cord injuries or disorders)
Health care providers with face-to-face contact with Veterans with SCI/D
Infection control Chiefs/Officers
In the United States, H1N1 influenza has been widespread, resulting in many infections, hospitalizations, and deaths. Due to impaired respiratory function following injury, persons with spinal cord injuries and disorders (SCI/D) are at extremely high risk from respiratory complications that occur as a result of contracting influenza.
The overall goal is to understand approaches used to prevent/reduce influenza transmission in the SCI/D System of Care in response to the 2009 H1N1 pandemic, in addition to seasonal influenza. Due to the rapid spread of and uncertainties about the H1N1 virus, one objective is to evaluate patient's beliefs, behaviors, and information seeking strategies (e.g., social media). The other objective is to assess infection control strategies used by SCI staff (and perceptions of) and guidance provided by local infection control units.
Multiple data collection efforts will be used to evaluate strategies used and their impact to address influenza (H1N1 and seasonal) in the VHA SCI/D population. At the facility level, the guidance provided by local infection control units in general and specific to SCI/D will be assessed via a semi-structured interview with infection control Chiefs/liaisons. An anonymous survey will be conducted to assess SCI health care providers' beliefs about and use of infection control strategies (vaccination and non-vaccine methods such as personal protective equipment, hand hygiene practices, appropriate work attendance practices) in addition to their perceptions of strength of evidence for H1N1 prevention measures, resource availability, and outreach by local infection control to facilitate infection prevention strategies. In addition, Veterans with SCI/D will be surveyed about their beliefs and information seeking strategies (e.g., social media) about seasonal and H1N1 influenza during the most recent influenza season, in addition to occurrence of influenza/ILI, receipt of influenza vaccination (H1N1 and/or seasonal) during the current influenza vaccination period, and perceived adverse effects from vaccination. Finally, the use of antiviral medications to treat influenza in Veterans with SCI/D, a two-group retrospective pre-posttest review of all visits and admissions associated with influenza (or related) diagnosis and/or antiviral prescription will be conducted. Charts for Veterans with SCI/D and Veterans who do not have SCI/D will be reviewed and compared for differences in practices in the SCI/D population versus the general veteran population.
This study will provide critical information that can be used to improve compliance with and understanding of influenza vaccination and infection control strategies at the patient, provider, and facility levels. These findings will lend to the understanding of ways to handle emergent issues, such as the H1N1 pandemic, in special populations.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01270685
|United States, Illinois|
|Edward Hines, Jr. VA Hospital|
|Hines, Illinois, United States, 60141-3030|
|Principal Investigator:||Sherri L. LaVela, MPH MBA PhD||Edward Hines Jr. VA Hospital|